{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PRF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRF\",,,,,undefined,":{"symbol":"PRF","market":"US","secType":"STK","nameCN":"Invesco RAFI US 1000 ETF","latestPrice":43.34,"timestamp":1753473600000,"preClose":43.18,"halted":0,"volume":218193,"hourTrading":{"tag":"盘后","latestPrice":43.1701,"preClose":43.34,"latestTime":"17:00 EDT","volume":271,"amount":11700.7961,"timestamp":1753477223023},"delay":0,"floatShares":184080000,"shares":184080000,"eps":1.60003,"marketStatus":"Closed","change":0.16,"latestTime":"07-25 16:00:00 EDT","open":43.26,"high":43.36,"low":43.1,"amount":9441087.176376,"amplitude":0.006021,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.60003,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753689600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":43.18,"sharesOutstanding":182990000,"nav":43.20121,"aum":7905389417.9,"dividendRate":0.017305,"bidAskSpread":0.000248,"postHourTrading":{"tag":"盘后","latestPrice":43.1701,"preClose":43.34,"latestTime":"17:00 EDT","volume":271,"amount":11700.7961,"timestamp":1753477223023},"volumeRatio":0.588858,"impliedVol":0.095,"impliedVolPercentile":0.656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRF\",,,,,undefined,":{"symbol":"PRF","floatShares":184080000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.588858,"shares":184080000,"dividePrice":0.75,"high":43.36,"amplitude":0.006021,"preClose":43.18,"low":43.1,"week52Low":34.98,"pbRate":"--","week52High":43.445,"institutionHeld":0,"latestPrice":43.34,"eps":1.60003,"divideRate":0.017305,"volume":218193,"delay":0,"ttmEps":1.60003,"open":43.26,"prevYearClose":40.34,"prevWeekClose":42.66,"prevMonthClose":42.27,"prevQuarterClose":42.27,"fiveDayClose":42.66,"twentyDayClose":41.92,"sixtyDayClose":39.15},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PRF\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":0.003746},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":0.003746}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528745203","title":"Microchip Completes Radiation-Hardened Power MOSFET Family to MIL-PRF-19500/746 and Achieves JANSF 300 Krad Capability","url":"https://stock-news.laohu8.com/highlight/detail?id=2528745203","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528745203?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"Designed for extreme environments and conditions, radiation-hardened MOSFETs are available from 100 Krad to 300 Krad Total Ionizing Dose. CHANDLER, Ariz., April 17, 2025  -- The JANS qualification represents the highest level of screening and acceptance requirements, ensuring the superior performance, quality and reliability of discrete semiconductors for aerospace, defense and spaceflight applications. Microchip Technology  today announces its completion of its family of radiation-hardened  power MOSFETs to the MIL-PRF-19500/746 slash-sheet specification and the achievement of JANSF qualification for its JANSF2N8587U3, 100V N-channel MOSFET to 300 Krad  Total Ionizing Dose .Microchip’s JANS series of rad-hard power devices is available in voltage ranges from 100–250V to 100 Krad  TID, with the family expanding to higher Radiation Hardness Assurance  levels, starting with the JANSF2N7587U3 at 300 Krad  TID. The JANS RH MOSFET die is available in multiple package options including a pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/microchip-completes-radiation-hardened-power-120000036.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1720051108.HKD","LU0006061336.USD","LU1720051017.SGD","LU1861215975.USD","PW","LU1861214812.USD","LEO","BK4559","LU2360107325.USD","RH","BK4605","BK4084","BK4585","LU0724618433.USD","ON","BK4588","MCHP","LU0124384867.USD","PRF","LU2357305700.SGD","BK4136","MCHPP","LU1861219969.SGD","LU1978683503.SGD","BK4141","LU1854103824.USD","LU1854104046.USD","LU1548497426.USD","LU0348723411.USD","IE00BZ199S13.USD","LU2298322129.HKD","BK4512","LU1861220033.SGD","BK4234","BK4178","IE00BD6J9T35.USD","SEE"],"gpt_icon":0},{"id":"2494381267","title":"BRIEF-PainReform Provides Further Update On Phase 3 Clinical Trial Of PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494381267?lang=en_us&edition=fundamental","pubTime":"2024-12-27 23:24","pubTimestamp":1735313098,"startTime":"0","endTime":"0","summary":"Dec 27  - PainReform Ltd   :   * PAINREFORM PROVIDES FURTHER UPDATE ON PHASE 3 CLINICAL TRIAL OF PRF-110   * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD COULD NOT BE CLARIFIED TO SATISFY STUDY'S PRIMARY ENDPOINT 72 HOURS REQUIREMENT   * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD DID NOT MEET PRIMARY ENDPOINT OF STUDY   * PAINREFORM LTD - INITIATES RESEARCH AND DEVELOPMENT ACTIVITIES TO REFINE PHARMACO-KINETICS AND PHARMACO-DYNAMICS OF PRF-110Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRF","BK4585","PRFX","BK4588"],"gpt_icon":1},{"id":"2494385472","title":"PainReform Faces Setback in Phase 3 Trial for PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2494385472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494385472?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:17","pubTimestamp":1735309031,"startTime":"0","endTime":"0","summary":"PainReform ( ($PRFX) ) has provided an update. PainReform announced that its Phase 3 clinical trial for PRF-110 did not meet its primary endpoint o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-faces-setback-in-phase-3-trial-for-prf-110?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-faces-setback-in-phase-3-trial-for-prf-110?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRF","BK4007","PRFX","BK4585","BK4588"],"gpt_icon":0},{"id":"2494002038","title":"PainReform Phase 3 trial on PRF-110 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2494002038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494002038?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:35","pubTimestamp":1735306536,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) announced an update regarding its Phase 3 clinical trial evaluating PRF-110 in post-surgical pain management of patients undergoi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-phase-3-trial-on-prf-110-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-phase-3-trial-on-prf-110-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PRF","BK4007","BK4588","PRFX"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRF\",params:#limit:5,,,undefined,":[{"date":"2025-06-23","symbol":"PRF","amount":0.17508,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PRF","amount":0.18939,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PRF","amount":0.19719,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"},{"date":"2024-09-23","symbol":"PRF","amount":0.18655,"announcedDate":"2024-09-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-27"},{"date":"2024-06-24","symbol":"PRF","amount":0.17326,"announcedDate":"2024-06-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRF\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-18","recordDate":"2015-09-22","paymentDate":"2015-09-30","value":0.47975,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2015-12-31","value":0.73856,"currency":"USD"},{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-31","value":0.32975,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-30","value":0.43751,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.48773,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRF\",market:\"US\",delay:false,,,undefined,":{}}}